DAFNA Capital Management as of Sept. 30, 2013
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 52 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharmacyclics | 15.4 | $14M | 102k | 138.26 | |
| Protalix BioTherapeutics | 5.8 | $5.3M | 1.2M | 4.53 | |
| Stereotaxis (STXS) | 5.8 | $5.3M | 1.6M | 3.33 | |
| AtriCure (ATRC) | 5.7 | $5.2M | 478k | 10.98 | |
| Novadaq Technologies | 5.1 | $4.7M | 284k | 16.58 | |
| Insulet Corporation (PODD) | 5.0 | $4.5M | 125k | 36.24 | |
| Insulet Corporation Cvt 3.75 0 convert | 4.8 | $4.4M | 3.0M | 1.45 | |
| Discovery Laboratories | 4.3 | $4.0M | 2.0M | 1.96 | |
| NxStage Medical | 3.6 | $3.3M | 252k | 13.16 | |
| Ampio Pharmaceuticals | 3.5 | $3.2M | 426k | 7.50 | |
| Biotelemetry | 3.3 | $3.1M | 309k | 9.91 | |
| Given Imaging | 3.3 | $3.0M | 156k | 19.23 | |
| Ariad Pharmaceuticals | 3.0 | $2.7M | 149k | 18.40 | |
| Curis | 2.6 | $2.4M | 530k | 4.46 | |
| Inspiremd | 1.8 | $1.7M | 715k | 2.33 | |
| Cardica | 1.5 | $1.4M | 1.1M | 1.30 | |
| Wright Medical Group Inc note 2 000 8/1 | 1.3 | $1.2M | 1.0M | 1.23 | |
| Conatus Pharmaceuticals | 1.3 | $1.2M | 116k | 10.05 | |
| Venaxis | 1.2 | $1.1M | 590k | 1.94 | |
| Kalobios Pharmaceuticals | 1.2 | $1.1M | 250k | 4.52 | |
| XenoPort | 1.2 | $1.1M | 191k | 5.68 | |
| BioSpecifics Technologies | 1.1 | $1.0M | 52k | 19.46 | |
| Nuvasive Inc. conv | 1.1 | $970k | 1.0M | 0.97 | |
| Uroplasty | 1.1 | $958k | 289k | 3.31 | |
| Spectranetics Corporation | 1.0 | $880k | 52k | 16.81 | |
| Neuralstem | 0.9 | $847k | 313k | 2.71 | |
| Galena Biopharma | 0.9 | $855k | 375k | 2.28 | |
| Biota Pharmaceuticals | 0.9 | $845k | 202k | 4.18 | |
| Johnson & Johnson (JNJ) | 0.9 | $815k | 9.4k | 86.70 | |
| Syneron Medical Ltd ord | 0.9 | $784k | 91k | 8.62 | |
| Cutera (CUTR) | 0.9 | $789k | 89k | 8.90 | |
| Keryx Biopharmaceuticals | 0.8 | $748k | 74k | 10.09 | |
| Derma Sciences | 0.8 | $706k | 57k | 12.38 | |
| Merrimack Pharmaceuticals In | 0.8 | $687k | 181k | 3.79 | |
| Exactech | 0.7 | $678k | 34k | 20.16 | |
| Novavax | 0.7 | $662k | 210k | 3.15 | |
| Intercept Pharmaceuticals In | 0.7 | $663k | 9.6k | 69.08 | |
| RTI Biologics | 0.7 | $625k | 167k | 3.74 | |
| Dyax | 0.6 | $518k | 76k | 6.86 | |
| Masimo Corporation (MASI) | 0.5 | $466k | 18k | 26.63 | |
| Baxano Surgical I | 0.5 | $468k | 336k | 1.39 | |
| Tg Therapeutics (TGTX) | 0.4 | $378k | 75k | 5.04 | |
| Achillion Pharmaceuticals | 0.4 | $368k | 122k | 3.02 | |
| Idera Pharmaceuticals | 0.4 | $348k | 200k | 1.74 | |
| Theragenics Corporation | 0.4 | $350k | 161k | 2.18 | |
| Graymark Healthcare | 0.3 | $284k | 693k | 0.41 | |
| Palatin Technologies | 0.3 | $258k | 375k | 0.69 | |
| Biolase Technology | 0.2 | $213k | 112k | 1.91 | |
| Tonix Pharmaceuticls | 0.2 | $164k | 45k | 3.64 | |
| Authentidate Holding | 0.1 | $126k | 142k | 0.89 | |
| Ocera Therapeutics | 0.1 | $67k | 7.9k | 8.49 | |
| Combimatrix Corporation *w exp 05/01/ | 0.0 | $999.750000 | 2.3k | 0.43 |
